Global Contrast Injector Market was valued US$ 481.86 Mn in 2019 and is expected to reach US$ XX by 2026, at a CAGR of XX % during a forecast period.
The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region.
To know about the Research Methodology:-Request Free Sample Report
High prevalence of cardiovascular & neurological disorders, a large number of approvals for contrast agents in different geographies, and growing demand for minimally invasive surgeries are propelling the global contrast injector market growth.
The high cost of contrast media injectors, the side effects and allergic reactions associated with contrast agents are limiting the global contrast injector market growth.
Based on regions, the global contrast injector market is divided into five main regions are America, Europe, Asia-pacific, Latin America and Middle East & Africa.
On the basis of product, the consumables segment is estimated to account for the largest share of the contrast injector market owing to the recurring use of consumables in diagnostic procedures to maintain hygienic conditions. The consumables segment is further divided into injector heads, syringes, tubing, and other consumables.
The injector systems segment is further divided into CT injector systems, MRI injector systems, and angiography injector systems. CT injector systems segment is expected to command the largest share of the market. The MRI injector systems segment is expected to grow at the highest CAGR during the forecast period.
In the application segment, interventional cardiology is projected grow at the highest rate during the forecast period because of the rising prevalence of cardiac diseases, such as coronary artery disease, heart valve disease, increasing use of contrast agents in various diagnostic procedures & centers, and peripheral vascular disease
High prevalence of cardiovascular & neurological disorders, a large number of approvals for contrast agents in different geographies, and growing demand for minimally invasive surgeries are propelling the global contrast injector market growth.
The high cost of contrast media injectors, the side effects and allergic reactions associated with contrast agents are limiting the global contrast injector market growth.
The key opportunity of the contrast injector market is ongoing advancement in contrast media injectors.
Geographically, the Asia-Pacific region is growing with the highest CAGR during the forecast period due to the increase in the installation of medical imaging equipment and procedures. The growth of the contrast injector market in the Asia-Pacific region is attributed to economic growth, which is led to increased disposable income and consequently, increased the affordability of sophisticated imaging technology, increasing population of old people.
Moreover, a large population base and growing geriatric population, which is more prone to cardiovascular and certain neurological disorders, would lead to a large potential patient base.
The report provides a comprehensive analysis of the key players operating in the global contrast injector market such as Bracco S.p.A, Bayer AG, Guerbet Group, Medtron AG, Ulrich GmbH & Co. KG, GE Healthcare, Shenzhen Seacrown Electromechanical Co., Ltd, Nemoto Kyorindo Co. Ltd., Sino Medical- Device Technology Co., Ltd., and Vivid Imaging.
Scope of Global Contrast Injector Market: Inquire before buying
Global Contrast Injector Market, by Product:
• Injector Systems
• Consumables
• Accessories
Global Contrast Injector Market, by Application:
• Interventional Radiology
• Interventional Cardiology
• Radiology
Global Contrast Injector Market, by End User:
• Diagnostics Centers
• Clinics
• Hospitals
• Others
Global Contrast Injector Market, by Region:
• North America
• Europe
• Middle East & Africa
• Asia Pacific
• Latin America
Key players operating in Global Contrast Injector Market:
• Bracco S.p.A
• Bayer AG
• Guerbet Group
• Medtron AG
• Ulrich GmbH & Co. KG
• GE Healthcare
• Shenzhen Seacrown Electromechanical Co., Ltd
• Nemoto Kyorindo Co. Ltd.
• Sino Medical- Device Technology Co., Ltd.
• Vivid Imaging.
For More Information Visit @: https://www.maximizemarketresearch.com/market-report/global-contrast-injector-market/20839/
This Report Is Submitted By: Maximize Market Research Company
Customization of the report:
Maximize Market Research provides free personalized of reports as per your demand. This report can be personalized to meet your requirements. Get in touch with us and our sales team will guarantee provide you to get a report that suits your necessities.
About Maximize Market Research:
Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.
